DIABECELL®

uses pig islets to replace human islets that have been destroyed by type 1 diabetes.

DOL works within a whole community of universities, consortiums and companies to deliver on the promise of Xenotransplantation by developing real treatments that make a real difference.  You can link to some of the exciting developments in the field from here: